Low serum apolipoprotein A1 level predicts poor prognosis of patients with diffuse large B-cell lymphoma in the real world: a retrospective study

Xiaoling Huang,Ying Wang,Zhenyu Huang,Xuzheng Chen,Qiuyan Lin,Haobo Huang,Liping Fan
DOI: https://doi.org/10.1186/s12885-024-11818-5
IF: 4.638
2024-01-14
BMC Cancer
Abstract:Apolipoprotein A1 (ApoA1) is a member of the apolipoprotein family with diverse functions. It is associated with the pathogenesis and prognosis of several types of tumors. However, the role of serum apolipoprotein A1 (ApoA1) in the prognosis of patients with diffuse large B-cell lymphoma (DLBCL) remains unclear. This study aimed to elucidate its influence on clinical outcomes in patients with DLBCL.
oncology
What problem does this paper attempt to address?